Stephen R. Bloom

Part of Imperial College London, I C Consultants Ltd. is a consulting British company. The company is based in London, UK. The CEO of the company is Alistair James McDermott.

NeuroTargets, Inc. develops novel therapeutic products. It discovers and develops new drugs for neurological diseases. The company develops products in the fields of diabetic neuropathy, pain resulting from nerve damage, spinal cord injuries and other trauma, and brain diseases associated with cognitive impairment such as stroke and Alzheimer's disease. NeuroTargets was founded in 1999 and is located at Guildford, UK.

The National Institute for Biological Standards & Control operates as a center for medicines and healthcare products. The non-profit company is based in Potters Bar, UK.

The Medical Research Society provides medical research services.

Society for Endocrinology is a non-profit organization that aims to promote public education in endocrinology. The non-profit company is based in Bristol, UK, and has subsidiaries in the United Kingdom. The British company has developed a podcast series called "Hormones: The Inside Story" that uncovers the facts about hormones and health using an expert-led, myth-busting, and often amusing format. The podcast aims to counter the misinformation and potentially dangerous advice from non-experts and dubious commercial enterprises that are prevalent in the mainstream media. The company also develops the program for the annual SfE BES conference and have an Endocrine Ambassador program to encourage students and colleagues to join the Society for Endocrinology.

The British Diabetic Association is a leading charity in the UK that funds world-class diabetes research. The non-profit company is based in the UK. The British company has around 120 diabetes research projects at any given time, which are made possible by the support of their members, donors, and local groups. Each research project is reviewed by experts and approved by their research committee and panel of people living with diabetes. The company's vision is a world where diabetes can do no harm, and they invest in pioneering research into all forms of diabetes and diabetes-related complications. In 2021, they invested over £6.4 million in diabetes research to kick start 31 new studies. The company was founded in 1934 by HG Wells, RD Lawrence.

Thiakis Ltd. develops hormone-based treatments for obesity and other metabolic diseases. It focuses to commercialize an effective anti-obesity treatment based on a peptide hormone called oxyntomodulin. The company was founded in 2004 by Steve Bloom and John Burt and is headquartered in Sandwich, the United Kingdom.